JEMO-PHARM A/S: Financial statements 2019
CVR: 10216109
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 5,906,000 and a net result of DKK -6,078,000 compared with DKK 23,000 the year before. That is a decrease of 39.4% compared with the year before. Equity in the 2019 report amounted to DKK -3,517,000. The company had 25 employees in the financial year.
- Gross Profit
- DKK 5,906,000
- Profit/Loss
- DKK -6,078,000
- Equity
- DKK -3,517,000
- Total Assets
- DKK 39,248,000
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 5.9 mio. | -6.1 mio. | -3.5 mio. | 25 |
| 2018 | - | 9.8 mio. | 23 t. | 2.6 mio. | 20 |
| 2017 | - | 9 mio. | 522 t. | 2.5 mio. | 17 |
| 2016 | - | 8.7 mio. | 549 t. | 2 mio. | 20000 |
| 2015 | - | - | -2.9 mio. | 1.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
JEMO-PHARM A/S has published its annual report for 2018. Gross profit came to DKK 9,753,000, and the net result was DKK 23,000.
About JEMO-PHARM A/S
JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named CMA TERADATA A/S and TERADATA A/S. The management consists of Mikael Andreas Mohr. The board consists of Svend Aage Dreist Hansen (chair), Henrik Winther Olsen and Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity in the 2025 report amounted to DKK 10,041,000.